Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes

18 Oct 2021

Abstract excerpt

Background. Bladder cancer is the tenth most common cancer worldwide. Valuable biomarkers in the field of diagnostic bladder cancer are urgently required. Method. Here, the gene expression matrix and clinical data were obtained from The Cancer Genome Atlas (TCGA), GSE13507, GSE32894, and Mariathasan et al. Five prognostic genes were identified by the univariate, robust, and multivariate Cox’s regression and were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Ferroptosis and cancer prognosis
Share to Inflammasome and immune disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34708131
DOI: 10.1155/2021/3236384

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune LandscapesPMID 34708131Read ↗

Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancerSemantic proximity Read ↗

Development of A Prognostic Index and Screening of Prognosis Related Genes Based on an Immunogenomic Landscape Analysis of Bladder CancerSemantic proximity Read ↗

Construction of a new prognosis prediction model and immune infiltration analysis of bladder urothelial cancer based on disulfidptosis-related immune genesSemantic proximity Read ↗

ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatmentSemantic proximity Read ↗

Telomere maintenance-related genes are important for survival prediction and subtype identification in bladder cancerSemantic proximity Read ↗

A Five-Gene Stromal-EMT Signature Predicts Prognosis, Immunotherapy Resistance, and Therapeutic Vulnerability in Bladder CancerSemantic proximity Read ↗

Disulfidptosis related immune genes drive prognostic model development and tumor microenvironment characterization in bladder urothelial carcinomaSemantic proximity Read ↗

Prognostic value of immunogenic cell death genes in bladder cancerSemantic proximity Read ↗

Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA)Semantic proximity Read ↗

Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironmentSemantic proximity Read ↗

Construction of a Novel T Cell Subtype with Immunotherapeutic Value in Bladder Cancer and a Neural Network-Based Prognostic ModelSemantic proximity Read ↗

Targeting Macrophage-Associated Core Genes for Prognostic Prediction and Therapeutic Insights in Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.